tenk.fyi

Lexeo Therapeutics, Inc.

LXEONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$100.0M

1.7% YoY

EPS

$-1.86

39.8% YoY

Cash

$63.0M

79.9% YoY

FY 2025 · As of 2025-12-31